7.11

0.42% 0.03

Teladoc Health Inc (TDOC)

Overview News Price History Option Chain Financials Discussions Forecast

Teladoc Health Inc stock is traded at $7.11, with a volume of 3.48M. It is up +0.42% in the last 24 hours and down -9.77% over the past month. Teladoc Health Inc is engaged in virtual care, forging a new healthcare experience with Better convenience, outcomes, and value. Its mission is to empower all people everywhere to live their healthiest lives by transforming the healthcare experience. It operates in Teladoc two segments Health Integrated Care and BetterHelp segments. The majority of its revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems.

Previous Close:

$7.08

Open:

$7.14

24h Volume:

3.48M

Relative Volume:

0.44

Market Cap:

$1.24B

Revenue:

$2.59B

Net Income/Loss:

$-981.73M

P/E Ratio:

-1.2322

EPS:

-5.77

Net Cash Flow:

$206.95M

1W Performance:

+0.71%

1M Performance:

-9.77%

6M Performance:

-22.97%

1Y Performance:

-41.91%

1-Day Range:

$7.03

$7.24

1-Week Range:

$6.725

$7.27

52-Week Range:

$6.35

$15.21

Teladoc Health Inc Stock (TDOC) Company Profile

Name

Teladoc Health Inc

Sector

Healthcare (1153)

Industry

Health Information Services (53)

Phone

(203) 635-2002

Address

2 MANHATTANVILLE ROAD, PURCHASE, NY

Employee

5,500

Twitter

@teladoc

Next Earnings Date

2024-10-30

Latest SEC Filings

TDOC's Discussions on Twitter

Compare TDOC with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
TDOC Teladoc Health Inc	7.11	1.24B	2.59B	-981.73M	206.95M	-5.77
VEEV Veeva Systems Inc	237.05	38.54B	2.75B	714.14M	1.09B	4.33
DOCS Doximity Inc	59.19	11.13B	516.85M	174.11M	217.38M	0.87
TEM Tempus Ai Inc	61.37	9.87B	640.44M	-743.28M	-206.93M	-11.29
HQY Healthequity Inc	90.40	7.83B	1.15B	96.70M	-161.99M	1.09
WAY Waystar Holding Corp	40.01	7.04B	906.14M	-52.62M	89.62M	-0.3621

Teladoc Health Inc Stock (TDOC) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-15-24	Initiated	Goldman	Buy
Sep-17-24	Reiterated	Jefferies	Hold
Feb-29-24	Initiated	Cantor Fitzgerald	Overweight
Feb-26-24	Initiated	Leerink Partners	Market Perform
Jan-17-24	Downgrade	DA Davidson	Buy → Neutral
Jan-03-24	Initiated	Barclays	Overweight
Apr-12-23	Initiated	Stephens	Equal-Weight
Feb-23-23	Upgrade	SVB Securities	Market Perform → Outperform
Oct-24-22	Upgrade	Guggenheim	Sell → Neutral
Sep-16-22	Initiated	KeyBanc Capital Markets	Sector Weight
Sep-07-22	Initiated	Truist	Hold
Aug-17-22	Downgrade	Guggenheim	Neutral → Sell
Aug-12-22	Initiated	DA Davidson	Buy
Aug-02-22	Downgrade	Berenberg	Buy → Hold
Aug-02-22	Downgrade	Cowen	Outperform → Market Perform
Jul-28-22	Downgrade	Goldman	Buy → Neutral
Jul-28-22	Downgrade	Needham	Buy → Hold
Jul-06-22	Reiterated	BofA Securities	Neutral
May-05-22	Downgrade	Argus	Buy → Hold
Apr-28-22	Downgrade	Citigroup	Buy → Neutral
Apr-28-22	Downgrade	Credit Suisse	Outperform → Neutral
Apr-28-22	Downgrade	Guggenheim	Buy → Neutral
Apr-28-22	Downgrade	JP Morgan	Overweight → Neutral
Apr-28-22	Downgrade	SVB Leerink	Outperform → Mkt Perform
Apr-28-22	Downgrade	Wells Fargo	Overweight → Equal Weight
Apr-28-22	Downgrade	William Blair	Outperform → Mkt Perform
Apr-07-22	Initiated	Guggenheim	Buy
Apr-01-22	Resumed	Credit Suisse	Outperform
Mar-03-22	Upgrade	Argus	Hold → Buy
Feb-23-22	Reiterated	BofA Securities	Neutral
Feb-23-22	Reiterated	Craig Hallum	Hold
Feb-23-22	Reiterated	Evercore ISI	In-line
Feb-23-22	Reiterated	Goldman	Buy
Feb-23-22	Reiterated	JP Morgan	Overweight
Feb-23-22	Reiterated	KeyBanc Capital Markets	Overweight
Feb-23-22	Reiterated	Needham	Buy
Feb-23-22	Reiterated	Oppenheimer	Outperform
Feb-23-22	Reiterated	Stifel	Hold
Feb-11-22	Initiated	Goldman	Buy
Feb-08-22	Reiterated	Piper Sandler	Overweight
Dec-02-21	Resumed	Jefferies	Hold
Nov-22-21	Downgrade	BTIG Research	Buy → Neutral
Oct-28-21	Reiterated	Barclays	Equal Weight
Oct-28-21	Reiterated	BofA Securities	Neutral
Oct-28-21	Reiterated	Canaccord Genuity	Buy
Oct-28-21	Reiterated	Citigroup	Buy
Oct-28-21	Reiterated	Craig Hallum	Hold
Oct-28-21	Reiterated	Needham	Buy
Oct-28-21	Reiterated	Oppenheimer	Outperform
Oct-28-21	Reiterated	Piper Sandler	Overweight
Oct-28-21	Reiterated	UBS	Neutral
Oct-19-21	Initiated	Wells Fargo	Overweight
Aug-02-21	Downgrade	Argus	Buy → Hold
Jul-28-21	Downgrade	Deutsche Bank	Buy → Hold
May-28-21	Initiated	Robert W. Baird	Neutral
Apr-15-21	Initiated	Needham	Buy
Jan-07-21	Initiated	BTIG Research	Buy
Dec-22-20	Initiated	Evercore ISI	In-line
Dec-07-20	Downgrade	Stephens	Overweight → Equal-Weight
Dec-04-20	Initiated	Goldman	Neutral
Nov-13-20	Upgrade	Robert W. Baird	Neutral → Outperform
Sep-22-20	Initiated	DA Davidson	Buy
Sep-02-20	Upgrade	Berenberg	Hold → Buy
Aug-17-20	Upgrade	Credit Suisse	Neutral → Outperform
Jul-14-20	Initiated	Citigroup	Buy
Jul-13-20	Initiated	Argus	Buy
Jul-07-20	Initiated	Stephens	Overweight
Apr-30-20	Reiterated	KeyBanc Capital Markets	Overweight
Apr-13-20	Initiated	SVB Leerink	Outperform
Mar-31-20	Downgrade	Berenberg	Buy → Hold
Mar-25-20	Downgrade	Craig Hallum	Buy → Hold
Mar-16-20	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight
Mar-12-20	Downgrade	Robert W. Baird	Outperform → Neutral
Feb-28-20	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
Feb-12-20	Downgrade	Wells Fargo	Overweight → Equal Weight
Jan-10-20	Initiated	UBS	Neutral
Jan-09-20	Downgrade	BofA/Merrill	Buy → Neutral

View All

Teladoc Health Inc Stock (TDOC) Latest News

02:20 AM

(TDOC) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com

02:20 AM

May 08, 2025

Digital health companies faced a rocky start to 2025 - Modern Healthcare

May 08, 2025

TDOC Q1 Loss Narrower Than Estimates on Strong Integrated Care Unit - TradingView

May 08, 2025